FDA NDC Directory · JSON-LD · Markdown

Besponsa

NDC 0008-0100 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameinotuzumab ozogamicin
Labeler / ManufacturerWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Marketing categoryBiologic License Application · App BLA761040
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsINOTUZUMAB OZOGAMICIN (.25 mg/mL)
Marketing started20170818
Package count1

External sources

Source: openFDA. Public-domain (CC0).